Laboratory Reference Grade Compounds

SLU-PP-332 (10mg Research Vial)

RUO In-VitroLyophilized Powder≥99% Reference Standard
Protocol SOP↓
₱2,950.00
Out of stock
Net Content10MG
InclusionVial Only
Volume Discounts:Up to 20% OFF
1
SOPReconstitution Telemetry (10MG)
Diluent:mL
Concentration10.00 mg/mLin 1.0mL BAC
Standard Dose500 mcg – 2000 mcg Daily SubQ / OralSyringe: 10.0 units (0.10 mL)
Scale (1 Unit)100 mcgper 0.01 mL (U-100)
• Lyophilized vial onlyMonograph SOP →
SLU-PP-332 (10mg Research Vial)10MG · Vial Only
₱2,950.00
1
Technical Specification & Protocol Dossier

Analytical Standards & Laboratory Handling

Verified laboratory protocols, reconstitution parameters, and handling guidelines.

P

Pharmacological Profile & Mechanism of Action

Research Monograph

What it is: SLU-PP-332 is a novel synthetic small molecule that acts as a potent pan-agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ), crucial nuclear transcription factors regulating cellular mitochondrial biogenesis.

How it works: By selectively activating ERR receptors, SLU-PP-332 mimics the genetic expression cascade induced by aerobic endurance training, dramatically increasing mitochondrial fatty acid oxidation and cellular endurance in skeletal muscle fibers.

Why researchers study it: Investigated as an 'exercise-in-a-bottle' mimetic for muscle wasting, metabolic syndrome, and cardiac function preservation.

Compound & Molecular Specifications

Certificate of Analysis Standards
Target CategoryMetabolic Signaling & Incretins
Intended ApplicationLaboratory & In-Vitro Research Only (RUO)
Physical StateLyophilized Solid Powder
CAS Registry Number299173-19-4
PubChem CID5472852↗
Molecular Weight345.32 g/mol
Purity Specification≥99.0% (HPLC-grade)
Net Content Options10MG
Inclusion PackagesVial Only, Vial + BAC Water, Analytical Lab Set
Peptide Sequence / FormulaC18H14F3N3O